Latest news
First Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 13:04:40 GMTPriovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS) - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 11:00:00 GMTObsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 11:05:00 GMTNurix enrolls first patient in phase 3 trial for CLL drug - Investing.comInvesting.com · Tue, 04 Aug 2026 05:12:46 GMTNurix Therapeutics Announces First Patient Enrolled in Phase 3 DAYBreak CLL-306 Study of Bexobrutideg in Relapsed/Refractory CLL/SLL - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 05:10:00 GMTNurix Phase 3 Trial Tests Bexobrutideg Against CLL Standard of Care - Stock TitanStock Titan · Tue, 04 Aug 2026 05:03:02 GMTVDyne enrolls first patient in IDE study of tricuspid valve - MassDeviceMassDevice · Wed, 29 Jul 2026 07:00:00 GMTOrbusNeich Enrols First Patient in Pivotal Japanese Trial of Coronary Drug-Coated Balloon - BioPharma APACBioPharma APAC · Wed, 29 Jul 2026 00:07:57 GMT